Serotonin has been shown to be a neuromodulator in the Aplysia californica CNS. The diversity of serotonin actions is due to the existence of several different receptor subtypes. In this study we report the cloning of a full-length cDNA, coding for a novel serotonin receptor (5-HT ap2 ). The receptor protein bears the characteristics of G protein-coupled receptors. It shares 68% and 34% of its amino acid sequence identity with the 5-HT lym receptor from Lymnaea stagnalis and the mam- The expression of 5-HT ap2 restricted to the CNS suggests an important role for this receptor in the modulation of neuronal functions in Aplysia. Moreover, the high expression of 5-HT ap2 in the bag cells, associated with its pharmacological pro®le, suggests that this receptor may be implicated in modulating the afterdischarge during the egg-laying behavior.
Over the last 20 years, important progress has been made in understanding the cellular and molecular mechanisms underlying behavioral plasticity and learning. In these processes, the modulation of ionic conductance is mediated by the combined integrated action of several neurotransmitters, among which serotonin (5-HT; 5-hydroxytryptamine) selectively regulates different neuronal systems through the activation of distinct receptor subtypes (Cassel and Jeltsch 1995; Buhot 1997; Gerhardt and Heerikhuizen 1997; Meneses 1998; Pauwels 2000) .
In the mollusk Aplysia californica, 5-HT is associated with different behaviors (Hen 1993; Walters and Ambron 1995; Pittenger and Kandel 1998) . In this invertebrate, one of the most studied behaviors is a withdrawal reflex, where 5-HT induces short-and long-term synaptic changes in sensory neurons (for review see Glanzman 1995; Pittenger and Kandel 1998) . Similarly, 5-HT modulates the function of peptidergic neurons involved in the reproductive behavior of Aplysia (Jennings et al. 1981) . As observed in mammals, the stimulation of different 5-HT-receptor subtypes (Drummond et al. 1980; Kadan and Hartig 1988; Emptage and Carew 1993; Sun et al. 1996) leads to the production of distinct second messengers through the activation of multiple effectors such as adenylate cyclase (Bacskai et al. 1 1993 ) and phospholipase C (Ghirardi et al. 1992; Li et al. 1995) . A rise in second messengers then leads to the activation of protein kinase C (Ghirardi et al. 1992; Byrne and Kandel 1996) , protein kinase A (Ghirardi et al. 1992; Bacskai et al. 1993 ) and mitogen-activated protein kinase (MAP kinase) (Martin et al. 1997) .
Despite the crucial role of the serotoninergic system in Aplysia behavior, little is known about the characteristics of its molecular components. In Aplysia, 5-HT acts on at least six different receptor subtypes to activate different postsynaptic responses (Gerschenfeld and Paupardin-Tritsch 1974 2 ; Kadan and Hartig 1988) . So far, only three 5-HT receptors have been characterized in this invertebrate. Li et al. (1995) cloned two closely related receptors, Ap5-HT B1 and Ap5-HT B2 , that stimulate phospholipase C in response to 5-HT and are expressed in the CNS (Ap5-HT B2 ) and in the reproductive system (Ap5-HT B1 ). However, they could not be readily grouped within any of the mammalian subgroups based on amino acid sequence identity. The third receptor gene encoded a 5-HT 1 -like receptor, negatively coupled to adenylate cyclase and expressed in various tissues (Angers et al. 1998) . However, the contribution of these receptors to the numerous physiological functions modulated by 5-HT in Aplysia is unknown.
In order to gain insight into the molecular characterization of other serotonergic receptors in Aplysia, we isolated a new 5-HT receptor (5-HT ap2 ) with significant sequence and structural homologies with the 5-HT 1 receptor family. Transient expression in HEK 293 cells confirms this analysis, demonstrating that this receptor is negatively coupled to adenylate cyclase in response to 5-HT. Using RT-PCR, a restricted expression was detected in the central nervous system, suggesting a potential role for this protein in the modulation of synaptic connections and neuronal properties.
Materials and methods

Animals and compounds
Aplysia californica weighing 100±200 g were purchased from the Aplysia Resource Facility (Miami, FL, USA) or from Marine Specimen Unlimited (Pacific Palisades, CA, USA), maintained in an aerated seawater tank at 15°C and fed every day ad libitum.
[N-methyl- ATP, cyclic AMP (cAMP), 5-carboxamidotryptamine maleate (5-CT), clozapine N-oxide, dopamine hydrochloride, forskolin (+/±)-8-hydroxy-dipropylaminotetralin hydrobromide (8-OH-DPAT), 5-hydroxytryptamine (5-HT), isobutylmethyxanthine (IBMX), ketanserin tartrate, metergoline, methiothepin mesylate, hydrobromide, octopamine and p-aminophenetyl-m-trifluoromethylphenyl piperazine (PAPP) were purchased from Sigma-Aldrich (Oakville, Ontario, Canada).
PCR amplification and cloning of 5-HT ap2 cDNA Phage DNAs (200 ng) isolated from an Aplysia random-primed kGT10 CNS cDNA library was PCR-amplified for 40 cycles (94°C for 1.5 min, 40°C for 2 min and 72°C for 1 min) in the presence of two degenerate primers (800 ng each) corresponding to the highly conserved receptor sequences found in the sixth and seventh transmembrane (TM) domains: 5¢-(G,C)IGCITT(T,C)ITIITITG (C,T)TGG(C,T)TGG(C,T)TICCITT(C,T)TT-3¢, and 5¢-TCIGGII (A,T)(G,A)AAIATIG(T,C)(G,A)TA(G,A)ATIA(T,C)IGG(A,C)TT-3¢. PCR products were fractionated on a 4% agarose gel and a 147-bp fragment (5-HT ap2A ) was subcloned into pCR 2.1 plasmid (Invitrogen, Carlsbad, CA, USA) and sequenced according to the Sequenase protocol (United States Biochemical Corp., Cleveland, OH, USA) 3
. To clone the full-length cDNA, we performed PCR-amplifications on the same phage DNAs using sense and antisense 5-HT ap2 -specific primer (5¢-GACGAGCGGAACATTCCCATC-3¢ and 5¢-GAT-GGGAATGTTCCGCTCGTC-3¢) and two kGT10-specific primers (5¢-AGCAAGTTCAGCCTGGTTAGTC-3¢ and 5¢-CTTATGAGTA-TTTCTTCCAGGGTA-3¢). The products of these PCR-amplifications (5-HT ap2B and 5-HT ap2C ) were subcloned into PCR 2.1 or pZAPA/TA vectors, and sequenced (Fig. 1a) . pZAPA/TA plasmid was constructed by ligating two complementary oligonucleotides (5¢-AGCTTCCATGGATATCATGGCCAACAAAACCATGGG-3¢ and 5¢-AATTCCCATGGTTTTGTTGGCCATGATATCCATGGA-3¢) containing XcmI sites between the EcoRI±HindIII sites of pBluescript vector (Stratagene, La Jolla, CA, USA). Digestion with the restriction enzyme XcmI produces single thymidine (T) overhangs allowing cloning of unmodified PCR products. To obtain the missing 5¢ end of the transcript we performed a final PCRamplification using an antisense 5-HT ap2B -specific primer (5¢-CTGTTATGTCTGAATCATTGTTAGGG-3¢) and the kGT10-specific primer described above (5-HT ap2D ; Fig. 1a ). All PCRamplifications were performed with the proofreading polymerase Vent from New England Biolabs (Mississauga, Ontario, Canada). Overlapping sequences were read from multiple clones generated from independent PCR amplifications.
Transient expression and immunofluorescence
The coding region of 5-HT ap2 was PCR-amplified with the Vent DNA polymerase and the primer pair 5¢-CCATCGATGAC-GACTCCGGGACACTTAGCTC-3¢ and 5¢-CCATGCATTTCAAT-CGTCACTGGTGCCC-3¢ (underlined: ClaI restriction site). The product was subcloned in pZAPA/TA vector and sequenced. The product was digested with ClaI and BamHI and subcloned in frame with the c-myc epitope in pcDNA3/RSV/MYC. The pCDNA3/RSV/ MYC plasmid was previously obtained by adding the c-myc epitope EQKLISEEDLN (Degols et al. 1991; Cravchik and Matus 1993) to the pcDNA3/RSV vector (Jockers et al. 1996) . Human embryonic kidney cells (HEK 293) and monkey kidney cells (COS-7) were transfected with the recombinant plasmid by calcium phosphatemediated transfection. Cells were collected 48 h post-transfection for functional assays.
For immunofluorescence, COS-7 cells transiently expressing 5-HT ap2 were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min at room temperature. The cells were then blocked with 1% bovine serum albumin (BSA) in PBS. Cells were incubated with the anti-myc 9E10 monoclonal antibody (Santa Cruz Bitoechnology Inc., Santa Cruz, CA, USA), or with a rabbit anticalnexin antibody (Sigma-Aldrich, Oakville, Ontario, Canada) for 1 h at room temperature in PBS containing 0.1% BSA. For intracellular labelling, cells were permeabilized with 0.3% Triton X-100 in PBS containing 0.1% BSA. Cells were washed in permeabilization buffer and incubated with Texas red-conjugated species-specific secondary antibodies (Jackson Immuno-Research Laboratories, West Grove, PA, USA) in blocking buffer for 1 h. Mounting was done in ImmunoFluor mounting medium (ICN, Costa Mesa, CA, USA). Cells were visualized by immunofluorescence, using 63X plan Apochromat objective of a Zeiss Axioskop fluorescence microscope.
Ligand binding analysis
Membranes were prepared from 5-HT ap2 -transfected HEK 293 cells as described by Hebert et al. (1996) 
cAMP accumulation
The cAMP content was measured by the pre-labeling technique, as described by Ansanay et al. (1992) . Cells were incubated with 2 lCi/mL [ 3 H]adenine overnight. Five times 10 5 cells per point were then washed and incubated with 2.5 mM IBMX, 1 lM forskolin and the indicated drugs in a final volume of 300 lL PBS for 20 min at 37°C. The reaction was stopped by aspiration of the medium and addition of 500 lL of ice-cold 5% trichloroacetic acid. A 100-lL solution of carrier (5 mM ATP and 5 mM cAMP) was added to the mixture. Cellular proteins were centrifuged at 5000 g. Tissue distribution studies Total RNA extracted from the CNS, kidney, gill, ovotestis, buccal mass, heart, ganglia of the nervous system and the bag cells were purified using RNeasy Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions, reverse-transcribed, and PCR-amplified with the OneStep RT-PCR Kit (Qiagen) for 35 cycles (94°C for 1 min, 54°C for 1 min and 72°C for 1.5 min) with the primer pair 5¢-TCTTATCTGCTGGCTACCC-3¢ and 5¢-TTCAGCGTGTTCTCCTTACGTC-3¢ (nucleotides 1616±1864). The PCR products were fractionated on a 2% agarose gel. As positive control, we used actin primers as described in DesGroseillers et al. (1994) .
Afterdischarge measurements
All experiments were performed at room temperature (22°C) on isolated abdominal ganglia. Before dissection, the animals were anesthetized with the injection of an isotonic MgCl 2 solution (385 mM) corresponding to approximately a third of their volume. Dissection of the abdominal ganglia was performed in a cold (4°C) extracellular medium made from equal volumes of 385 mM MgCl 2 and artificial sea water (ASW; NaCl 460 mM, KCl 10 mM, CaCl 2 11 mM, MgCl 2 55 mM and HEPES buffer 10 mM pH 7.6). Both pleuro-abdominal connectives were cut close to the pleural ganglion. The ganglia were pinned to the bottom of a Sylgard-coated chamber (3 mL volume) filled with 2 mL ASW. The right connective (approximately 2 mm) was aspirated into a suction electrode for stimulation. All preparations were rested under constant superfusion of ASW for 1 h; this rest period was followed by an additional rest of 30 min. The bag cell afterdischarge was initiated by electrical stimulation of the right connective (15 s pulse train at 6Hz, 23 V, 2.5 ms duration) and recorded with an extracellular electrode placed over the right bag cell cluster. The afterdischarge was monitored with a chart recorder at 5 mm/s (initial part of the afterdischarge) and 1 mm/s (later part). 5-HT and 5-CT were added to the bath 2 min 45 s after the end of connective stimulation (3 min after its beginning). The drugs were added directly to a static bath (2 mL volume) to obtain a final desired concentration of 1 lM. We used separate preparations to evaluate the various treatments because a second bag cell afterdischarge is generally difficult to obtain from a single preparation within a single day (Kaczmarek et al. 1978) .
Results
Cloning and structural characteristics of 5-HT ap2
Using degenerate primers based on the peptidic sequences of the sixth and the seventh transmembrane domains of serotonergic G protein-coupled receptors (GTP binding protein; GPCR), and cDNAs derived from an Aplysia kGT10 CNS library, a fragment of 147 bp was amplified, cloned and sequenced. In order to clone the complete cDNA sequence, we used nested oligonucleotides derived from the cloned cDNA fragment (5-HT ap2A ) and primers derived from the kGT10 vector sequence. Three overlapping clones (5-HT ap2B , 5-HT ap2C and 5-HT ap2D ) covering 1876 bp of the 5-HT ap2 sequence were amplified and cloned (Fig. 1a) . The 1876-bp reconstituted cDNA contains an open reading frame encoding a protein of 567 amino acids with a predicted molecular mass of 63 kDa (Fig. 1b) .
Hydrophobicity analysis of the deduced protein reveals the presence of seven transmembrane domains characteristic of GPCRs (data not shown). The 5-HT ap2 protein displays several key features common to mammalian and invertebrate serotonin receptors. In particular, Asp173 residue in TM-II, the tripeptide DRY (Asp224±Arg225±Tyr226) at the interface of TM-III and the second intracellular loop, and the NPXXY motif (Asn539±Pro540±Tyr543) in TM-VII are conserved. These residues were shown to be important for receptor activation in members of the subfamily 1A of GPCRs (Boess and Martin 1994; Oliveira et al. 1994; Bockaert and Pin 1999) 4 . Others amino acids that are conserved in all known G protein-coupled 5-HT receptors were also found (Fig. 1b) . Sequences that were used for phylogenetic analysis were retrieved from the GenBank database. The sequences of serotonin receptors were compared and aligned using the ClustalW (Thompson et al. 1994 ) which was executed from GDE (Genetic Data Environment, J. Felsenstein, 1993, Phylip, Phylogeny Inference Package, version 3.5.1c and 3.6, University of Washington, Seattle, WA, USA). Only amino acid positions that could be aligned without ambiguity were used for the analysis. The alignment was then used for phylogenetic comparisons using the PHYLIP package (J. Felsenstein, 1993, Phylip, Phylogeny Inference Package, version 3.5.1c and 3.6, University of Washington, Seattle, WA). Analysis was performed with a bootstrap procedure that computes the probability of occurrence of the branches for 1000 possible trees. Branching order was determined using the Fitch-Margoliash algorithm included in the PHYLIP package. Only branches occurring in > 800 trees are represented. APL, Aplysia; DRO, Drosophila; FUG, Fugu rubripes (puffer®sh); LYM, Lymnaea; HUM, human; MUS, mouse. 5-HT ap2 may potentially undergo several post-translational modifications ( Fig. 1b) : (i) N-glycosylation in the extracellular amino part and in the second extracellular loop; (ii) phosphorylation by protein kinase A, protein kinase C or casein kinase II. No cysteine residues are present within the C-terminal tail, suggesting that this receptor is not palmitoylated. Its large third cytoplasmic loop and its short carboxy tail are reminiscent of members of vertebrate 5-HT 1 receptor family (Boess and Martin 1994 ; Fig. 1b) . Amino acid sequence comparisons between the 5-HT ap2 receptor and other 5-HT receptors show significant sequence identity to the 5-HT 1 -like receptors (Fig. 2a) , and a dendrogram analysis places 5-HT ap2 within the family of mammalian 5-HT 1 receptors (Fig. 2b) .
A Southern blot analysis of genomic DNA reveals that the 5-HT ap2 gene is probably intronless and does not have a close homolog in the Aplysia genome. Indeed, a single band was observed when the restriction enzymes used to digest the DNA do not cut in the region covered by the probe, and two bands are present when the restriction sites are present in the probe sequence (Fig. 3 ). Similar results were described for the 5-HT 1 -like Aplysia receptor 5-HT ap1 (Angers et al. 1998) , and this genomic organization seems to be a common feature of several genes of the 5-HT 1 subfamily (Gerhardt and van Heerikhuizen 1997) . Characterization of an Aplysia 5-HT 1 receptor 339 terminus. The resulting recombinant protein was transiently expressed in HEK 293 cells. Expression of the receptor was monitored with an anti-myc monoclonal antibody. In the immunoblot, a band with an apparent molecular weight of 63 kDa was detected (Fig. 4a) . The size of this band corresponds to the predicted molecular weight of the 5-HT ap2 receptor monomer. Bands of higher molecular weight were also detected. These bands may represent oligomers, as oligomerization of serotonin receptors have recently been reported (Lee et al. 2000) .
To confirm that the 5-HT ap2 receptor is expressed at the cell-surface, the myc-tagged protein was transiently expressed in COS-7 cells. Immunofluorescence analysis of non-permeabilized cells showed that the 5-HT ap2 receptor is expressed at the cell surface of COS-7 cells (Figs 4b)1) . In the same conditions, immunofluorescence signal was not detected with the anti-calnexin antibody, a specific marker of the rough endoplasmic reticulum (Figs 4b)3) . Upon cellpermeabilization, calnexin was detected within the expected cellular compartment (Figs 4b)4).
Pharmacological characterization
To determine whether the 5-HT ap2 cDNA encoded a functional receptor, we isolated membranes from HEK 293 cells in which we transiently expressed the 5-HT ap2 receptor. Membranes bound [ 3 H]LSD in a saturable and dose-dependent manner with an estimated K d of 4.37 nM (Fig. 5a) . No binding was observed on membranes from cells transfected with the pCDNA3/RSV vector (data not shown).
We next tested the ability of various serotoninergic agonists and antagonists to displace [ 3 H]LSD from HEK 293 cells in which we transiently expressed the 5-HT ap2 receptor. The rank order of affinity of these drugs is listed in Table 1 , and illustrated in Fig. 5(b) . As expected, 5-HT displayed a higher affinity for the receptor than dopamine and octopamine. Except for 5-HT, clozapine and ketanserin, the pharmacological profile of 5-HT ap2 is similar to the one reported for the 5-HT lym receptor (Table 1) (Sugamori et al. 1993) .
5-HT ap2 signaling
In order to test whether the 5-HT ap2 receptor is a new member of the 5-HT 1 receptor family, we measured the variations in the [ 3 H]cAMP level following 5-HT application. In transiently transfected cells, we did not detect an increase in the level of cAMP in response to serotonin (data not shown). This was expected because the molecular structure and pharmacological profile of the 5-HT ap2 receptor suggested that it is coupled to G i , and therefore inhibits adenylate cyclase. To confirm this hypothesis, we first stimulated adenylate cyclase with forskolin and then measured the level of cAMP following 5-HT application. In these conditions, forskolin-induced cAMP accumulation was efficiently inhibited by 5-HT (Fig. 6 ). The same result was obtained with the agonist 5-CT. This effect was dosedependent and saturable, the potencies for 5-HT and 5-CT being consistant with their respective rank of affinities for inhibition of [ (Table 1 ). In addition, 5-HT produced no inhibition of cAMP accumulation in the presence of 1 nM of the antagonist methiothepin (data not shown). Pertussis toxin (PTX), a known G i protein inhibitor, at a concentration of 50 ng/mL, completely blocked the effect of 5-HT, indicating that 5-HT ap2 receptor interacts with a PTX-sensitive G protein. Interestingly, treatment with PTX not only inhibits G i -dependent decrease of cAMP level but also seems to unveil a functional coupling between 5-HT ap2 and G s -protein that produces an increase in the cAMP level (Fig. 6) . Examples of such dual coupling to G s and G i pathways have been reported (Eason and Liggett 1995; Xiao et al. 1995) . As a control, increasing concentration of 5-HT had no effect on cAMP levels in untransfected HEK cells treated with forskolin (data not shown). These experiments demonstrate that activation of 5-HT ap2 receptor inhibits adenylate cyclase and cAMP accumulation through its functional coupling to a mammalian G i protein in HEK 293 cells. In addition, under certain physiological circumstances, 5-HT ap2 might also be coupled to G s and increase cAMP level.
Tissue distribution of 5-HT ap2 transcripts in Aplysia
To determine the presence of the 5-HT ap2 mRNA in various tissues of Aplysia, we used a RT-PCR-based screening strategy on total RNA isolated from the Aplysia CNS, kidney, ovotestis, gill, buccal mass and heart. Using 5-HT ap2 -specific primers, a 248 nt fragment was PCRamplified only in the CNS (Fig. 7a) . In this tissue, the 5-HT ap2 mRNA could be detected in the abdominal ganglion (without the bag cells), in the bag cells and also weakly in the cerebral and pleural-pedal ganglia (Fig. 7b) . Expression was confirmed by Southern blotting and hybridization with a 5-HT ap2 -specific oligonucleotide (data not shown).
5-HT application inhibits afterdischarge in the bag cells
Since 5-HT ap2 is expressed in bag cells, we tested its possible involvement in the regulation of the afterdischarge by focusing on the effect of two drugs selected for their high affinity for 5-HT ap2 : the agonist 5-CT and the antagonist methiothepin. The afterdischarges were initiated by the electrical stimulation of the right connective. After application of 1 lM of 5-HT, we observed a rapid decrease in the number of spikes per minute (Fig. 8a) , reflecting afterdischarge inhibition. The same effect can be obtained by application of the agonist 5-CT (1 lM). By contrast, pretreatment of the ganglia with 1 lM of the antagonist (lanes 1,7) , kidney (lanes 2,8), gill (lanes 3,9), ovotestis (lanes 4,10), buccal mass (lanes 5,11) and heart (lanes 6,12). The PCR products were visualized by ethidium bromide staining after seperation on a 2% agarose gel. Lower panel: PCR ampli®cation of a control gene (actin). Lanes 7±12: controls without reverse transcription. (b) Upper panel: RT-PCR ampli®cation of 5-HT ap2 from total RNA isolated from the abdominal ganglion (lanes 1,7), cerebral ganglion (lanes 2,8), pooled pleural and pedal ganglia (lanes 3,9), buccal ganglion (lanes 4,10), bag cells (lanes 5,11) and buccal mass (lanes 6,12). The PCR products were visualized by ethidium bromide staining after seperation on a 2% agarose gel. Lower panel: ampli®cation of a control gene (actin). Lanes 7±12: controls without reverse transcription.
methiothepin inhibited the effect of 5-HT on the bag cell afterdischarge (Fig. 8a) . The total duration of the afterdischarge in the control group ranged from 9.5 to 50 min with a median of 13.3 min (mean 21.23 9.64, n 5) (Fig. 8b) . The afterdischarge was significantly shorter in the groups treated with 5-HT and 5-CT. The median duration was 5.5 min (range 3.85±5.9, mean 5.18 0.456, n 4) and 5.72 min (range 4.33±9.18, mean 6.81 0.94, n 5), respectively. When the ganglia were pre-treated with the antagonist methiothepin (1 lM), the application of 5-HT had little effect. The median duration was 11.05 min (mean 11.67 2.267, n 4). Because of the demonstrated affinity of the drugs for 5-HT ap2 , and because 5-HT ap2 is present in the bag cells, these results can be interpreted as an indication that the cloned receptor may mediate the inhibition of afterdischarge by 5-HT in the bag cells.
Discussion
Results reported in this paper describe the characterization of 5-HT ap2 , an Aplysia californica 5-HT 1 -like receptor predominantly expressed in the CNS. The full-length nucleotide sequence encodes a protein of 567 amino acids, which shows the principal features of a G protein-coupled serotonin receptor, including seven hydrophobic transmembrane domains, putative N-linked glycosylation sites on its N-terminal side, and several phosphorylation consensus sequences. In particular, residues important for receptor activation in members of the subfamily 1A of GPCRs and others amino acids that are conserved in all known G proteincoupled 5-HT receptors were also found.
Structural and functional characteristics of 5-HT ap2
Sequence analysis reveals that 5-HT ap2 has a close amino acid identity (68%) with the Lymnaea stagnalis serotonin receptor 5-HT lym (Sugamori et al. 1993) , suggesting that they may be homologous. It is interesting to note that the highest sequence identity between 5-HT ap2 and 5-HT lym was found within the transmembrane sequences (94%). The actual working model of G protein-coupled receptors that are members of the subfamily 1A of GPCRs activated by small ligands like monoamines, suggests that the ligand-binding site is formed within the membrane (Bikker et al. 1998; Bockaert and Pin 1999) . Our results, demonstrating that these two receptors display similar pharmacological profiles when expressed in heterologous systems, are in good agreement with this model. The functional coupling of 5-HT lym to a second messenger system has not yet been determined and since this receptor presents a pharmacological profile and a general structure highly related to the 5-HT ap2 receptor, 5-HT lym may also be negatively coupled to adenylate cyclase.
5-HT ap2 also presents a high sequence identity with the Aplysia receptor 5-HT ap1 (37%) (Angers et al. 1998) , the 5-HT 1Ahum (34%) and the 5-HT dro2A receptors (29%), suggesting that the 5-HT ap2 receptor is associated with the mammalian 5-HT 1 family. This is in part confirmed by a dendrogram analysis which groups 5-HT ap2 with the members of the 5-HT 1 family, and by the pharmacological experiments that showed that 5-HT ap2 is negatively coupled to adenylate cyclase. However, its pharmacological profile displays important differences with those of the mammalian members of this subfamily. Methiothepin, a non-selective 5-HT antagonist, showed the strongest affinity. Its affinity for 5-HT ap2 was higher than those reported for its binding to any other cloned mammalian 5-HT receptors. Compounds like 5-HT and 5-carboxamidotryptamine (5-CT), which normally bind to mammalian 5-HT 1 receptors with high affinity (1±10 nM), showed a lower affinity for the 5-HT ap2 receptor. 8-OH-DPAT, a 5-HT 1A -specific agonist, PAPP, a 5-HT 1A agonist and 5-HT 1D antagonist, and NAN-190, a very The median values and the individual data points are illustrated. One outlayer data point (50 min) for the control group is not shown on the graph; however, this value is included in the median value and in the statistical analysis. A non-parametric Mann± Whitney (two-tailed) test was used to evaluate the differences between the groups. The U-and probability values were the following; control group versus 5-CT group, U 0, p 0.008; control versus 5-HT, U 0, p 0.016; 5-HT versus 5-HT in the presence of methiothepin U 0, p 0.028. specific 5-HT 1A antagonist, showed very poor affinity for 5-HT ap2 . Ketanserin and clozapine, two 5-HT 2 receptor antagonists, bound 5-HT ap2 with poor affinity. Metergoline, a 5-HT 1 , 5-HT 2 and 5-HT 7 antagonist, showed the same affinity for the Aplysia 5-HT ap2 receptor as for the mammalian 5-HT 1A and 5-HT 1D receptors. It is not surprising to find that the pharmacological profiles of 5-HT receptors from mollusks and mammals are difficult to compare, considering the large phylogenetic distances existing between these two classes (Sugamori et al. 1993; Angers et al. 1998; Tierney 2001) . These results suggest that the function of 5-HT ap2 receptor is probably closely related to those of an ancestor gene, which existed before the divergence of the 5-HT receptor subtypes in vertebrates, and that it kept characteristics of more than one receptor subtype.
The pharmacological profile of 5-HT ap2 is distinct from the one reported for 5-HT ap1 , another Aplysia 5-HT 1 -like receptor (Table 1 ). It will now be possible to discriminate between these receptors in 5-HT-induced physiological responses using appropriate agonists and/or antagonists.
Possible physiological roles of 5-HT ap2
The neuroendocrine bag cell clusters are involved in the regulation of the egg-laying behavior in Aplysia by generating a long-lasting afterdischarge, causing the release of the peptide egg-laying hormone (ELH) into the hemolymph (Stuart and Strumwasser 1980; Arch and Berry 1989 5 ; DesGroseillers 1990 ). This process was reported to be dependent on the stimulation of adenylate cyclase (Kaczmarek et al. 1978; Kauer and Kaczmarek 1985) . After discharge activity could be inhibited in a dose-dependent manner by extracellular application of low concentrations of serotonin (0.1±1 lM concentration range) (Jennings et al. 1981) and by the alpha bag cell peptide (a-BCP) (Kauer et al. 1987; Redman and Berry 1990) . Interestingly, inhibition of after discharge by a-BCP correlated with a reduction in cAMP levels in bag cell neurons (Kauer et al. 1987 ) and accordingly this effect was blocked by pre-treatment of the neurons with PTX, suggesting mediation by an inhibitory guanylate nucleotide-binding protein (G i protein) (Redman and Berry 1990) . It is likely that 5-HT inhibited after discharge by the same mechanism, therefore 5-HT ap2 receptor seems to be a good candidate for mediating this effect. Its high expression in the bag cells, its ability to inhibit adenylate cyclase through G i protein and the fact that the physiological doses of 5-HT and of the agonist 5-CT sufficient to inhibit after discharge were very close to the K i values of these compounds for the receptor, suggest that it may be involved in this function. After discharge inhibition cannot be achieved through activation of 5-HT ap1 , another Aplysia 5-HT 1 -like receptor, since it is not expressed in the bag cells (A. Angers and L. DesGroseillers, unpublished data) . However, we do not exclude the possibility that other receptors are expressed in bag cells and/or involved in modulation of after discharge. Previous studies have shown that 5-HT increases the level of cAMP in resting bag cells (Bernier et al. 1982; Bruehl and Berry 1985) 6 . These experiments were done with high concentrations of 5-HT (100 lM) and not during after discharge. It will be necessary to determine the level of cAMP during 5-HT-induced inhibition of the after discharge to determine whether this inhibition is blocked by pre-treatment with PTX.
Another reported function of serotonin is the 5-HTinduced potentiation of the acetylcholine-elicited contractions of the Aplysia buccal mass. Indeed, Ram et al. (1994) reported that an Aplysia 5-HT 1A -like receptor was present in this tissue and that this receptor presented pharmacological similarities to the gastropod 5-HT lym receptor. This effect was shown to be efficiently competed by the antagonist NAN-190 in the nanomolar range and mimicked by the agonist 8-OH-DPAT in the micromolar range. Despite the fact that the pharmacological behavior of 5-HT ap2 is similar to that described for 5-HT lym , we failed to detect the presence of 5-HT ap2 by RT-PCR in the buccal mass. This result suggests that 5-HT ap2 is probably not involved in this process, and that at least another 5-HT 1 -like receptor exists in this mollusk.
Is 5-HT ap2 involved in the signal transduction role that serotonin plays in the modulation of the withdrawal reflex? Storozhuk and Castellucci (1999) have observed that 5-HT depresses the sensory neuron connections in the RF cluster, a group of mechanoreceptor neurons for the withdrawal reflex. Receptors negatively coupled to adenylate cyclase such as 5-HT ap2 seem to be good candidates for this function. It will be particularly interesting to determine whether 5-HT ap2 is expressed in these neurons. Similarly, pathways in which activation of MAP kinases are implicated in the establishment of long-term facilitation are worth investigation (Martin et al. 1997) . Koch et al. (1994) demonstrated that stimulation of different G i -coupled receptors in different cell types leads to the activation of MAP kinases. In mammals, links between 5-HT receptors that inhibit adenylate cyclase and learning and memory processes have been established. Dependent on their localization in neurons, these receptors can act by inhibiting their firing rate and/or by decreasing their neurotransmitter release. For example, stimulation of 5-HT 1A receptors has been reported to generate detrimental effects on working memory in mice, whereas inactivation of these receptors antagonizes these effects (Buhot 1997) . Another example was reported by Buhot et al. (1995) who showed that stimulation of 5-HT 1B receptor, which is predominantly located on axon terminals, affects reference memory in rats. Further investigation on the localization of the 5-HT ap2 receptor in the Aplysia CNS, both at the cellular and subcellular levels, should provide us with some clues about its implication in the modulation of synaptic transmission that occurs during behavioral modifications. 
